Stifel’s weekly biopharma update covers biotech’s strong 2024 performance, Starboard Value’s activist move on Pfizer, and China’s shifting biotech sector, with data partly compiled by DealForma, plus insights on M&A trends and macroeconomic factors. Check out Stifel’s report.
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
